BioHarvest Sciences Pre-Tax Profit Margin 2020-2024 | BHST
BioHarvest Sciences pre-tax profit margin from 2020 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| BioHarvest Sciences Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-06-30 |
$0.02B |
$-0.02B |
-89.47% |
| 2024-03-31 |
$0.02B |
$-0.02B |
-118.75% |
| 2023-12-31 |
$0.01B |
$-0.01B |
-100.00% |
| 2023-09-30 |
$0.01B |
$-0.01B |
-90.00% |
| 2023-06-30 |
$0.01B |
$-0.01B |
-122.22% |
| 2023-03-31 |
$0.01B |
$-0.01B |
-142.86% |
| 2022-12-31 |
$0.01B |
$-0.01B |
-183.33% |
| 2022-09-30 |
$0.01B |
$-0.01B |
-200.00% |
| 2022-06-30 |
$0.00B |
$-0.01B |
-225.00% |
| 2022-03-31 |
$0.00B |
$-0.01B |
-166.67% |
| 2021-12-31 |
$0.00B |
$-0.01B |
-500.00% |
| 2021-09-30 |
$0.00B |
$-0.01B |
-1100.00% |
| 2021-06-30 |
$0.00B |
$-0.01B |
inf% |
| 2021-03-31 |
$0.00B |
$-0.01B |
inf% |
| 2020-12-31 |
$0.00B |
$-0.01B |
inf% |
| 2020-06-30 |
$0.00B |
$-0.00B |
inf% |
| 2020-03-31 |
$0.00B |
$-0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
